home    R&D    Ibrexafungerp

Ibrexafungerp

Anti-infective

 

CAS: 1207753-03-4

Indication: For the treatment of adult and postmenarchal pediatric females with vulvovaginal candidiasis (VVC).

Ibrexafungerp